candesartan has been researched along with Pulmonary Arterial Remodeling in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tarhouni, K | 1 |
| Freidja, ML | 1 |
| Guihot, AL | 1 |
| Vessieres, E | 1 |
| Grimaud, L | 1 |
| Toutain, B | 1 |
| Lenfant, F | 1 |
| Arnal, JF | 1 |
| Loufrani, L | 1 |
| Henrion, D | 1 |
1 other study available for candesartan and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Role of estrogens and age in flow-mediated outward remodeling of rat mesenteric resistance arteries.
Topics: Age Factors; Animals; Benzimidazoles; Biphenyl Compounds; Cyclic N-Oxides; Estrogens; Female; Hydral | 2014 |